Cetera Investment Advisers Guardant Health, Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 4,982 shares of GH stock, worth $479,517. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,982
Previous 4,961
0.42%
Holding current value
$479,517
Previous $211,000
22.75%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GH
# of Institutions
429Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.17 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.08 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$494 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$479 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$409 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.84B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...